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Abstract
Background: Coronary artery by-pass grafting (CABG) remains the optimal strategy in achieving complete
revascularization in patients with complex coronary artery disease. However, sternal wound infections (SWI),
especially deep SWI are potentially severe complications to the surgery. At the department of cardiothoracic
surgery in Uppsala University Hospital a gradual increase in all types of SWI occurred, which peaked in 2009.
This prompted an in-depth revision of the whole surgical process. To monitor the frequency of post-operative
infections all patients receive a questionnaire that enquires whether any treatment for wound infection has
been carried out.
Methods: All patients operated with isolated CABG between start of 2006 and end of 2012 were included in the study.
1515 of 1642 patients answered and returned the questionnaire (92.3 %). The study period is divided into the time before
the intervention program was implemented (2006-early 2010) and the time after the intervention (early 2010- end 2012).
To assess whether potential differences in frequency of SWI were a consequence of change in the characteristics of the
patient population rather than an effect of the intervention a retrospective assessment of medical records was performed,
where multiple of the most known risk factors for developing SWI were studied.
Results: We noticed a clear decrease in the frequency of SWI after the intervention. This was not a consequence of a
healthier population.
Conclusions: Our results from implementing the intervention program are positive in that they reduce the number of
SWI. As several changes in the perioperative care were introduced simultaneously we cannot deduce which is the most
effective.
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Background
Complete revascularization in patients with severe cor-
onary artery disease is optimally achieved with coronary
artery bypass-grafting (CABG) [1–3]. However, CABG is
also vitiated with complications, out of which one of the
most serious is sternal wound infection (SWI) [4]. SWI
leads to both increased patient morbidity and mortality
as well as augmented health care costs. Compared to a
CABG operation without SWI the median cost of a sin-
gle CABG procedure with SWI was $49.449 compared
to $18.218 [5]. The incidence of reported SWI following
CABG is highly variable due to differences in patient
profiles and surgical techniques. There are also differ-
ences in classification of the SWI, where most studies
have focused on the more severe, deep infections which
typically occur in 1–2 % of CABG operations [4] others
also report more superficial infections which are more
common, with incidences between 5–12.0 % [6, 7].
* Correspondence: rickard.lindblom@ki.se
1Department of Cardiothoracic Surgery and Anesthesia, Uppsala University
Hospital, 751 85 Uppsala, Sweden
Full list of author information is available at the end of the article
© 2015 Lindblom et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Lindblom et al. BMC Cardiovascular Disorders  (2015) 15:154 
DOI 10.1186/s12872-015-0148-4
There are a number of known patient-related, pre- intra-
and postoperative risk factors associated with increased
risk of developing SWI after CABG which have been stud-
ied extensively [6, 8]. Accordingly, major attempts have
been made to decrease the incidence of SWI. It is reason-
able to believe that strict adherence to good hygienic rou-
tines in the perioperative period is beneficial, and there is
documented evidence of the efficacy of hygiene interven-
tions in the setting of cardiac surgery [9, 10]. However,
these studies were small (less than 200 patients), spanned
short periods of time (1–2 years) and included mixed
patient groups, i.e. different kinds of open heart proce-
dures. Also, there are multiple challenges to overcome
when introducing changes in organizations [11]. In par-
ticular the leadership is challenged and methods of evaluat-
ing the performance of the clinic are of essence. Health
care processes are complex and multivariate. It is there-
fore recommended to analyze the events when a patient
is harmed or severely threatened to be so within the
health care process using a standardized method, for
instance a root cause analysis (The Swedish National
board of Health and Welfare, http://www.socialstyrel-
sen.se/patientsakerhet/ledningssystem/analyserarisker).
The focus of continuous event analysis should be on sys-
tem aspects and organizational issues and complications
identified related to the surgical care should be recorded
continuously [11]. Furthermore, collaboration with support
functions and other professions constitutes an important
step in improving medical organizations [12].
During 2009 especially the number of deep, but also super-
ficial, postoperative sternal wound infections within
30 days of surgery increased dramatically at the Depart-
ment of Cardiothoracic Surgery and Anesthesia, Upp-
sala University Hospital. This was considered a serious
problem and an extensive event analysis was performed.
The aim of the current study was to assess how the semi-
structured quality interventions that were implemented
following the campaign impacted on the number of self-
reported SWI 30 days after CABG.
Methods
Data collection
The study was performed at the department of Cardio-
thoracic Surgery and Anesthesia, Uppsala University
Hospital, Sweden. The unit performs around 700 open
heart surgeries annually out of which 250 to 300 are
isolated CABG. During the period between the start
2006 and the end of 2012 1642 patients underwent isolated
CABG. To evaluate the incidence of sternal wound infection
30 days after surgery a prospective, post-discharge patient
registered evaluation was performed (Additional files 1 and
2). The infections were self-reported and the response rate
was high throughout the study period; 1515 of 1642 patients
(92.3 % response rate) answered the post-discharge
evaluation. Any kind of postoperative SWI (superficial, sub-
cutaneous, to the sternum or deep/mediastinitis) that war-
ranted active treatment with either/or antibiotics or
surgical revision was included. 1334 (81.2) of the 1642 pa-
tients were men and 308 women (18.8 %). The mean age
was 67 ± 9 years.
To perform a more detailed study of potential risk factors
for SWI and better characterize the population a retrospect-
ive review of the medical records of every third patient, in
chronological order of operation date, that had answered
the post-discharge evaluation was selected and included in a
separate cohort (Fig. 1). 503 of 1515 (33.2 %) patients were
eligible for records review, the characteristics of this
cohort were similar to the whole study population re-
garding age and sex (age 67 ± 9, M/F 410/93, 81.5/
18.5 %). A chronological sampling, as opposed to stric-
ter randomization, was chosen in order to reflect the
seasonal fluctuations in operation volume and infection
frequency [13].
The review of the 503 medical records included specific
studies of patient-related risk factors such as age, gender,
body mass index (kg/m2), preoperative insulin-like growth
factor 1 (IGF-1) levels, diabetes, preoperative hemoglobin
Fig. 1 Illustration of the inclusion process
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concentrations, preoperative serum creatinine concentra-
tions, chronic obstructive pulmonary disease (COPD),
corticoid steroid treatment, current smoking status and
preoperative ejection fraction (EF). The review of intraop-
erative risk factors included the number of saphenous vein
grafts and internal mammary arteries used and the dur-
ation of cardiopulmonary by-pass and aortic cross clamp
time. The review of postoperative risk factors included if
erythrocyte transfusions had been given on day 0, 1 and 2
and also assessment of mean blood glucose concentration
day 0, 1 and 2. The day of operation was denoted as day 0
and day 1 started 6 am in the morning after surgery.
Hygiene routines before intervention
Preoperatively
Elective and semi-urgent cases were normally admitted
to the hospital the day before surgery, but sometimes
earlier. The patients had one shower at home and one
shower at the hospital. Hair removal on the leg and
chest hair was done using a disposable clipping machine
the night before surgery.
Intraoperatively
In the operating room, the skin was scrubbed with 0.5 %
chlorhexidine in 70 % ethanol, which was allowed to air
dry. The surgical procedures were performed in an operat-
ing room with ultra clean air with 10 cfu/m3. The staff
wore tightly woven scrub suits with cuffs and helmets
tucked under the neckline of the shirt. Cloxacillin, 2 g,
was administered intravenously three times a day for 2
days, starting in the morning of surgery.
Postoperatively
During the study period the policy of normalization of
blood glucose concentrations in the immediate postop-
erative period changed; for patients without diabetes it
was 5–7 mmol/l in 2006 to 2007 and 4–6 mmol/l from
2007 and onwards. For patients with diabetes the goal
was 5–7 mmol/l in 2008 to 2011. Wound dressings were
in the first period (2006–2010) allowed to stay in place
for 4 days if dry.
Changes in hygiene routines after intervention
When the increase in SWI was detected an action plan
was devised. Representatives from all personnel categories
(surgeons, anaesthesiologists, nurses and nurses aids) from
all three units (operation, intensive care unit and ward unit)
of the department as well as from the departments of Clin-
ical Microbiology and Infectious Medicine met at regular
intervals during September 2009–April 2010 to perform a
structured root cause analysis for infection according to
The National board of Health and Welfare (http://www.so-
cialstyrelsen.se/patientsakerhet/ledningssystem/
analyserarisker) and [14]. All elective operations ceased for
1 week. The changes in routines are summarized below.
Preoperatively
The preoperative washing routines were changed to two
showers and scrubbing with a 4 % chlorhexidine detergent
solution at the hospital. In the elective cases, care was
taken to admit the patients to the ward only on the day
before surgery, with a polyclinical meeting with a surgeon
several days before admittance in order to spend as little
time possible preoperatively in the hospital.
Intraoperatively
After the intervention the routine for antibiotic prophy-
laxis changed; Cloxacillin 2 g was instead administered
four to five times all in the day of surgery, every four
hours. The first dose started 30–60 min before the skin
incision to achieve the maximum concentration in the
blood at time of surgery.
A general policy of increased overall discipline in the
operating theatre, which aimed at restricting the number
of door-openings and minimizing the number of people
in the operating theatre (maximum 11) was enforced.
Regarding surgical technique, a standardized closure of
the sternotomy with preferably eight single sternal wires
that were not in figure-of-eights was introduced for all
surgeons. There are no RCT’s comparing closure tech-
niques, although there is some evidence from biomechan-
ical studies that supports the use of single wires as
compared to the figure-of-eight configuration [15, 16]. All
surgeons were urged to wear double gloves. Also, the
WHO checklist for Safe surgery was introduced [17]. At
the end of surgery the skin around the incision was
scrubbed with 0.5 % chlorhexidine in 70 % ethanol before
applying the wound dressing. Lastly, a revision of cleaning
procedures for the operation theatre and of reusable mate-
rials was done with purchase of disinfectable keyboards
and more disposable materials.
Postoperatively
In the second period (2010–2012) all sterile wound
dressings were removed after 48 h and the wound
inspected. No new dressing was added after this unless
the wound was still open in which case a new dressing
was placed after washing with sterile saline, the wound
was then inspected the next day again and the procedure
repeated if necessary. For patients with diabetes the
blood glucose goal was changed to 6–8 mmol/l from
2011 and onwards
General attitudes
In general, a higher level of alertness and adherence to
general and basic hand hygiene routines was enforced after
the intervention as well as the introduction of disposable
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plastic aprons to be worn during patient contact. To
ensure compliance general unannounced inspections were
performed throughout the clinic at regular intervals and
feed-back given to the staff, in all categories.
Statistics
Possible predictors for SWI were compared in patients
with and without SWI. Nominal data were analysed using
the X2 test. The Kolmogorov–Smirnov goodness-of-fit test
was used to analyse data distribution for the remaining risk
factors. If distributions deviated significantly (p < 0.05)
from the normal distribution the data were analysed using
the Mann–Whitney U or Kruskal–Wallis tests. Those vari-
ables not deviating from the normal distributions were
analysed using Student’s t-test or one-way analysis of vari-
ance (ANOVA). Variables are given as mean (and SD,
standard deviation), categorical variables as percentages.
Ethics, consent and permissions
The current work is the result of quality improvement
work performed at Department of Cardiothoracic Surgery
and Anesthesia, Uppsala University Hospital, Sweden and
adheres to the Declaration of Helsinki [18] as well as
national and local ethical guidelines for research http://




Initial analysis aimed to exclude any gross differences in
composition between the patient cohort selected for de-
tailed studies of medical records (n = 503), and the whole
study population during the period, i.e. the 1642 patients
operated with CABG between 2006 and end of 2012.
The populations had almost identical mean age and the
distribution between sexes was similar (Table 1 and Fig. 1).
Identification of risk factors associated with sternal
wound infection in the cohort
The characteristics of the cohort of patients that were se-
lected for retrospective analysis of medical records are de-
scribed in Table 2, where the patients that suffered SWI
are compared to the patients that did not suffer SWI, over
the whole study period. This revealed that the patients that
suffered from SWI more often had diabetes (p = 0.022)
and more often received blood transfusions on postop-
erative day 2 (p = 0.007) (Table 2). There was a strong
trend (p = 0.086) that lower preoperative hemoglobin
and higher levels of preoperative IGF-1 (p = 0.070) were
more prevalent in the SWI group. Noteworthy is that
the SWI group had a tendency to be younger than the
non-infected group (p = 0.053) (Table 2).
Patient profiles in period one compared to period two
To exclude that any potential differences in the rates of
SWI following CABG in the two study periods, i.e. before
and after the intervention, were an epiphenomena due to
differences in the study populations, assessment of the
profiles of the patient populations in the two periods was
performed. We therefore compared the whole groups, i.e.
both infected and non-infected patients grouped together,
from the two periods. This suggested that the two study
populations were largely similar with regard to patient-
related factors (Table 3). But there were some differences,
for instance in period one the preoperative IGF-1 was
slightly, but significantly higher, on the other hand, there
were significantly more patients in period two that were
on corticosteroid treatment. The groups were also similar
with regard to intraoperative factors (Table 3). However,
in the postoperative parameters there was one major dif-
ference between the groups, and this was the amount of
blood transfusions had significantly been reduced, from
18 to 9 %. Another minor difference was that the peri-
operative blood glucose was slightly higher in the second
period (Table 3).
Effect of the hygienic intervention of the frequency of
SWI
We next assessed whether the intervention program de-
creased the number of postoperative SWI; this was done
by comparing the incidence of SWI in period one, before
the intervention, with period two, after the intervention.
This demonstrated that the frequency of all kinds of SWI,
that is both deep and superficial, decreased from 12.2 % in
period one to 2.8 % (Table 4) in period two.
In period two the patients that suffered from SWI were
significantly younger than the healthy group, whereas in
period one there was no age difference between the
infected and non-infected (Table 4). Smoking was a risk
factor for developing SWI throughout the study period
(Table 4). Viewed over the whole study period, diabetes
was more common in the infected patients (Table 2),
whereas after the intervention there was no significant dif-
ference in the frequency of SWI between the patients with
or without diabetes (Table 4), although the number of in-
fected patients was small. In period one erythrocyte trans-
fusion on day 2 was associated with increased risk of SWI,
whereas this was not significant in period two (Table 4).
Table 1 Comparison between the population selected for









Age (years) 67 ± 9 67 ± 9 0.907
Sex M/F 410/93 923/241 0.874
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Microbial flora over time
Lastly, we investigated whether the hygienic intervention
could cause a shift or selection in the pathogenic micro-
flora involved in the SWI. The results are more thor-
oughly described in (Lytsy et al. [19], in press doi:10.1016/
j.jhin.2015.08.021). In summary there was no difference in
the proportion of the two most common pathogens
Staphylococcus aureus and Coagulase Negative Staphylo-
cocci in the pre- and post-intervention wound cultures.
Discussion
In this study we demonstrate our experience from imple-
menting an intervention program on reducing the inci-
dence of sternal wound infection following CABG. A
methodological and structured root cause analysis was per-
formed according to a standardized protocol. This meant
that a cross-professional review of the medical-, care- and
hygiene procedures, with a system of continuous monitor-
ing and feed-back was introduced. The discussion and work
that followed are continuous processes that ultimately aim
to enforce a higher level of alertness’ to all staff in the
optimization of the care of the patient. The aim of the
current study was not to primarily study risk factors for
developing SWI after CABG, as this has been extensively
performed before, but to assess whether the intervention
was meaningful, and to exclude that potential differences
were instead caused by a change in patient demographics.
Risk factor profiling
Analysis of the general risk factor profile of the patients
demonstrated that the burden of co-morbidities generally
associated with increased risk of postoperative infection
were not markedly different in period one compared to
period two, except for that there were half as many blood
transfusions in period two as in period one. This probably
contributes to some of the improvement seen in the
frequency of SWI after the hygienic intervention. Re-
operation for bleeding is a known risk-factor for devel-
oping SWI [19], and the reduction in the number of blood
transfusions could potentially have reflected a reduced
number of re-explorations for bleeding. However, when
reviewing the medical records of the 48 patients that suf-
fered SWI, none of them were re-operated for bleeding.
So, the reduction in blood transfusion does not reflect
Table 2 Characteristics of the infected and non-infected groups (n = 503) seen over the whole study period
Patients without infection (n = 455) Patients with infections (n = 48) p-value
Patient related riskfactors
Age (years) 67 ± 9 65 ± 10 0.053
Sex M/F 374/81 36/12 0.222
Body mass index (kg/m2) 28 ± 4 28 ± 4 0.954
Preoperative insulin-like growth factor 1 (mmol/mol) 45 ± 11 (n = 438) 51 ± 17 (n = 46) 0.070
Diabetes (%) 119/455 (26.5 %) 20/48 (41.7 %) 0.022 (*)
Preoperative hemoglobin concentrations (g/L) 141 ± 14 (451) 137 ± 11 (n = 47) 0.086
Preoperative serum creatinine concentrations (μg/L) 86 ± 28 (n = 452) 85 ± 23 (n = 47) 0.597
Corticoid steroid treatment (%) 12/455 (2.6 %) 2/48 (4.2 %) 0.540
Current smoking no/smoked the last 2 months/never smoked 54/314/87 7/36/5 0.319
Chronic Obstructive Pulmonary Disease (%) 12/455 (2.6 %) 1/48 (2.1 %) 0.818
Ejection fraction (%) 48 ± 9 (n = 348) 49 ± 10 (n = 35) 0.272
Intraoperative risk factors
Number of saphenous vein grafts (n) 3 ± 1 (n = 424) 3 ± 1 0.693
Internal mammary artery 0/1/2 41/412/2 2/46/0 0.621
Duration of cardiopulmonary by-pass time (min) 85 ± 29 (n = 453) 85 ± 27 0.683
Duration of aortic cross clamp time (min) 47 ± 19 (n = 453) 49 ± 19 0.634
Postoperative risk factors
Erythrocyte transfusion day 0 (%) 135/455 (29.7 %) 19/48 (39.6 %) 0.156
Erythrocyte transfusion day 1 (%) 71/455 (15.6 %) 10/48 (20.1 %) 0.349
Erythrocyte transfusion day 2 (%) 65/455 (14.3 %) 14/48 (29.2 %) 0.007 (**)
Mean blood glucose concentration day 0 (mmol/L) 7.8 ± 1.3 (n = 453) 7.5 ± 1.0 0.295
Mean blood glucose concentration day 1 (mmol/L) 8.2 ± 1.6 (n = 453) 8.5 ± 1.8 0.213
Mean blood glucose concentration day 2 (mmol/L) 9.0 ± 2.2 (n = 380) 9.4 ± 3.0 (n = 46) 0.788
*= p <0.05, **= p <0.01, **=p <0.001
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a reduced re-operation for bleeding in the infected group.
But blood transfusion per se has also been linked to devel-
opment of mediastinitis, often synonymous with DSWI
[21]. Consequently, the decline in transfusion rates in
period two may have contributed to the decrease in post-
operative infections, however, the 50 % reduction in blood
transfusions does not solely explain the almost 80 % re-
duction in SWI. This suggests that the action program
had significant additional effect, on top of that which
could be attributed reduced transfusion. It also suggests
that introduction of the action program as a positive side-
effect reduced the amount of blood transfusions, which in
any case is a desirable consequence.
Furthermore we saw that diabetes and erythrocyte
transfusions on day 2 after surgery were no longer associ-
ated with increased risk of SWI after the intervention,
suggesting that the changes implemented perhaps were
especially effective for these patients, although these num-
bers should be interpreted with caution as the infected
group in period two is small.
We did not see any association between higher blood
glucose and SWI, although the general ambition of con-
trolling blood glucose levels is high at our department
and both the infected and non-infected groups were
well regulated in this regard. With this said, it is therefore
still possible that poor glycemic control may be a risk for
SWI [22], although contradicting evidence exists, as
intense perioperative glucose monitoring has been shown
to not affect the rates of wound infection following car-
diac surgery, but to decrease mortality [23]. Other com-
monly studied factors like cross-clamp time or ECC
time were in our data not significant risk factors for
developing SWI.
The tendency for lower age in the infected group as
compared to the healthy group is somewhat surprising,
but could reflect a dimension not mirrored by the other
parameters, for instance genetic factors [24]. And since
they are operated with CABG at a young age, this may
suggest a more aggressive disease, rather than young age
being a risk factor per se for suffering SWI.
Table 3 Risk factors for self-reported sternal wound infection after coronary artery by-pass graft surgery in patients with review of
medical records (n = 503), comparison between into period one and two
2006–2010 to week 26 (Period 1) 2010 from week 27–2012 (Period 2) p-value
n = 362 n = 141
Patient related riskfactors
Age (years) 67 ± 9 67 ± 9 0.610
Sex M/F 73/289 121/20 0.121
Body mass index (kg/m2) 28 ± 4 28 ± 4 0.998
Preoperative insulin-like growth factor 1 (mmol/mol) 46 ± 12 44 ± 11 0.014 (*)
Diabetes (%) 94/268 (26 %) 45/96 (32 %) 0.180
Preoperative hemoglobin concentrations (g/L) 140 ± 14 141 ± 14 0.880
Preoperative serum creatinine concentrations (μg/L) 86 ± 28 87 ± 38 0.747
Chronic obstructive pulmonary disease (%) 12/350 (3.3 %) 1/140 (0.7 %) 0.098
Corticoid steroid treatment (%) 6/356 (1.7 %) 8/133 (5.7 %) 0.014 (*)
Current smoking/smoked the last 2 months/never smoked 46/246/70 15/104/22 0.444
Ejection fraction (%) 48 ± 9 49 ± 8 0.041 (*)
Intraoperative risk factors
Number of saphenous vein grafts (n) 3 ± 1 3 ± 1 0.982
Internal mammary artery 0/1/2 30/330/2 13/128/0 0.646
Duration of cardiopulmonary by-pass time (min) 85 ± 28 85 ± 29 0.744
Duration of aortic cross clamp time (min) 47 ± 19 48 ± 20 0.818
Postoperative risk factors
Erythrocyte transfusion day 0 (%) 118/244 (32.6 %) 36/105 (25.5 %) 0.123
Erythrocyte transfusion day 1 (%) 61/301 (16.9 %) 20/121 (14.2 %) 0.465
Erythrocyte transfusion day 2 (%) 66/296 (18.2 %) 13/128 (9.2 %) 0.013 (*)
Mean blood glucose concentration day 0 (mmol/L) 7.7 ± 1.3 8.2 ± 1.7 0.000 (***)
Mean blood glucose concentration day 1 (mmol/L) 8.2 ± 1.6 8.3 ± 1.8 0.408
Mean blood glucose concentration day 2 (mmol/L) 9.0 ± 2.3 8.9 ± 2.3 0.634
*= p <0.05, **= p <0.01, **=p <0.001
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In summary, the selected risk factors that proved to dif-
fer significantly between the infected and healthy group
were not new, although IGF-1 seems an interesting mol-
ecule to study further in these contexts, as there was a
strong trend (p = 0.07) for higher levels in the infected
group. There is to our knowledge no studies assessing the
link between high levels of IGF-1 and SWI. IGF-1 is a
good marker for nutritional status and anabolic responses
[25] and IGF-1 is often considered beneficial in wound
healing [26, 27], even though it has been shown detrimental
in parasitic skin infections [28]. IGF-1 is also
strongly linked to glucose-insulin pathways, however,
the link to diabetes is not altogether easy, as both high
and low levels of IGF-1 have been shown to correlate
with subsequent onset of diabetes [29]. Also, alterations
in the IGF-1 gene leads to lower levels of IGF-1, in turn
linked to a higher risk of developing both diabetes and
myocardial infarction [30]. The strong trend for ele-
vated levels of IGF-1 in the SWI group are therefore
difficult to interpret. And although we believe that, in
Table 4 Risk factors for self-reported sternal wound infection after coronary artery by-pass graft surgery in patients with review of
medical records (n = 503), comparison between into period one and two divided into infected and non-infected patients
2006–2010 to week 26
n = 362
2010 from week 27–2012
n = 141
Patients without
infection (n = 318)
87.8 %
Patients with
infections (n = 44)
12.2 %
p-value Patients without
infection (n = 137)
97.2 %
Patients with




Age (years) 67 ± 9 65 ± 10 0.198 68 ± 9 56 ± 7 0.032
(*)
Sex M/F 256/62 33/11 0.394 118/19 3/1 0.529
Body mass index (kg/m2) 28 ± 4 27.1 ± 4 0.606 28 ± 4 32 ± 4 0.051
Preoperative insulin-like growth
factor 1 (mmol/mol)
46 ± 11 (n = 307) 52 ± 18 (n = 42) 0.115 44 ± 11 (n = 131) 44 ± 8 0.917
Diabetes (%) 75/318 (23.6 %) 19/4443.2 % 0.005
(*)
44/137 (32.1 %) 1/4 (25 %) 0.763
Preoperative hemoglobin concentrations (g/L) 141 ± 14 (n = 315) 137 ± 11 (n = 43) 0.115 141 ± 14 (n = 136) 136 ± 11 0.467
Preoperative serum creatinine concentrations
(μg/L)
86 ± 22 (n = 243) 86 ± 23 (n = 43) 0.908 87 ± 39 70 ± 11 0.094
Chronic obstructive pulmonary disease (%) 11/318 (3.5 %) 1/44 (2.3 %) 0.680 1/137 (0.7 %) 0/4 0.864
Corticoid steroid treatment (%) 5/318 (1.6 %) 1/44 (2.3 %) 0.733 7/137 (5.1 %) 1/4 (25 %) 0.090
Current smoking/smoked the last 2 months/
never smoked




Ejection fraction (%) 47 ± 10 (n = 217) 49 ± 11 (n = 31) 0.222 49 ± 8 (n = 131) 51 ± 7 0.481
Intra-operative risk factors
Number of saphenous vein grafts (n) 3 ± 1 (n = 317) 3 ± 1 0.893 3 ± 1 (107) 4 ± 1 0.117
Internal mammary artery 0/1/2 28/288/2 2/42/0 0.675 13/124/0 0/4/0 0.518
Duration of cardiopulmonary by-pass time (min) 84 ± 2 (n = 317) 84 ± 28 0.886 85 ± 29 (n = 136) 90 ± 6 0.748
Duration of aortic cross clamp
time (min)
47 ± 18 (n = 317) 48 ± 19 0.929 48 ± 20 (n = 136) 53 ± 6 0.582
Postoperative risk factors
Erythrocyte transfusion day 0 (%) 100/318 (31.4 %) 18/44 (40.9 %) 0.209 35/137 (25.5 %) 1/4 (25 %) 0.980
Erythrocyte transfusion day 1 (%) 52/318 (16.4 %) 9/44 (20.5 %) 0.496 19/137 (13.9 %) 1/4 (25 %) 0.529
Erythrocyte transfusion day 2 (%) 53/318 (16.7 %) 13/44 (29.5 %) 0.038
(*)
12/137 (8.8 %) 1/4 (25 %) 0.268
Mean blood glucose concentration day 0
(mmol/L)
7.5 ± 1.1 (n = 317) 7.5 ± 1.0 0.916 8.2 ± 1.7 (n = 136) 7.6 ± 0.4 0.585
Mean blood glucose concentration day 1
(mmol/L)
8.1 ± 1.4 (n = 316) 8.5 ± 1.9 0.504 8.3 ± 1.8 8.1 ± 0.9 0.821
Mean blood glucose concentration day 2
(mmol/L)
9.0 ± 2.1 (n = 267) 9.4 ± 3.1 (n = 42) 0.902 8.9 ± 2.4 (n = 113) 9.1 ± 1.9 0.887
*= p <0.05, **= p <0.01, **=p <0.001
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our setting, elevated levels of IGF-1 could be seen as a
marker for poor metabolic control, this may be an over-
simplification, and instead reflect something more
complex.
A general impression at the clinic was that the propor-
tion of S.aureus decreased and the proportion of CoNS
increased in the infected wounds after the intervention.
However, statistical analysis of the wound cultures from
the patients that were surgically revised revealed no differ-
ences, as further discussed in (Lytsy et al. 2015, in press
doi:10.1016/j.jhin.2015.08.021). However, we lack wound
cultures from a majority of the superficial SWI, as they
were treated at other hospitals than Uppsala University
Hospital, and we can therefore not say if the intervention
affected the microbial population in the superficial SWI.
This constitutes an interesting question for further stud-
ies, especially as it has been shown that the use of a 4 %
chlorhexidine detergent solution can reduce the amount
of S.aureus colonization [31]. Even though this was in the
setting of pediatrics it could suggest that the extra pre-
operative shower with chlorhexidine that was added as
a part of the intervention could lead to less S.aureus
infections. Regarding chlorhexidine skin scrub, there is
also evidence from orthopedic surgery that postoperative
scrub of the wound with chlorhexidine may be effective in
reducing wound infections [32]. So we believe the chlor-
hexidine skin scrub at the end of surgery was an easy and
cost-effective measure to introduce, which may have con-
tributed to the beneficial outcome.
The complexity of assessing interventions
A weakness with the study is that the findings are correla-
tive, as no randomization or control group existed. Even
though the importance of hygiene in the setting of surgery
cannot be considered controversial, the degree of impact
can be discussed. The present study therefore to some
grade objectifies the significance of hygienic interventions.
Another aspect is that we have not analyzed the cost-
effectiveness of the program, merely the medical aspects.
Although we deem it most likely that the undertaken
actions have been a good investment, not only in decreased
patient suffering, but also economically as the cost of a
CABG with postoperative deep SWI is almost 3-fold to
that of a CABG without SWI [5], and many of the intro-
duced changes did not cost extra. However, this could be
the topic of further research.
It is difficult to assess the influence of individual inter-
ventions when multiple changes are introduced simultan-
eously. We can therefore not say which of the changes in
the perioperative routines had the most significant effect.
It is possible that some of the changes de facto were nega-
tive, but that this penetrance could have been blunted by
the stronger positive effect of another change. It is there-
fore important to constantly aim to improve, and not settle
for a final solution. To ultimately study the impact of indi-
vidual actions randomized clinical trials are warranted.
As often with patient-based collection of data there is
a risk for selection bias; it is possible that the patients
that suffered from SWI in a higher extent chose, or were
not able, to respond to the post-discharge evaluation.
But for the patients that were re-admitted for surgery,
i.e. the most severe infections, this data exists and is reli-
able, no matter if the patient answered the evaluation or
not. Also, the response rate was very good throughout
the study period, with no clear yearly variation. We
therefore find it reasonable to believe that the frequency
of non-responders were the same in the two periods,
and that the potential selection bias would affect both
periods similarly.
It should also be noted that the study includes all
kinds of SWI which means that a large spectrum of dis-
ease severity exists within the infected group. However,
main the purpose of the current study was not to specif-
ically study SWI morbidity or mortality, which has been
well studied before, but rather to evaluate the effect of
the intervention on the frequency of all types, i.e. both
superficial and deep, postoperative SWI. Ultimately all
kinds of SWI are best avoided, both for the sake of the
patients and the health care system.
Conclusions
The risk factors associated with developing SWI after
CABG are well studied but still not fully understood, and
tend to differ between materials [8]. The aim of the
current study was not to primarily study risk factors, this
was done with the goal to exclude that any differences in
outcome/SWI after the intervention were confounded by
differences in the study populations. This was to some ex-
tent the case as the number of blood transfusions were
significantly reduced after the intervention. However, this
did not explain the full difference, so it is still possible to
conclude that the program had effect in reducing SWI,
and as a positive side-effect reduced the number of blood
transfusions.
The problem of SWI is multifactorial, and it is not
possible to say where in the chain of events that surround
a CABG operation the infectious course starts. We there-
fore believe it is of essence that all levels of the clinic, from
operating surgeon to nurse assistant are engaged in the
process. Another important aspect, and difficulty, is to
maintain the increased discipline and accuracy with time,
and not settle for a final solution, after the changes have
been implemented and initial success achieved. With the
current study we show that a structured root cause ana-
lysis and a purposeful and stringent intervention program
can reduce the problem, although the exact importance of
each single change is difficult to define.
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